|
Sam Dryden is
internationally recognized as a successful
investor and developer of life-sciences
ventures. His particular expertise is in
the application, scale-up and commercialization
of early-stage technologies world-wide. Sam is
a Managing Director of Wolfensohn & Company, a
corporate advisory and investment firm located
in New York, where he focuses on private equity
investments in biofuels and other alternative
energies. he is also CEO of Emergent
Genetics, LLC - a life sciences investment
holding company.
Until June 2006, Sam served as the Chair and
Corporate CEO of Emergent Genetics, Inc. - a
global leader in the development and marketing
of biotechnology-enhanced seed products.
Emergent Genetics' operations were based in
Europe, the United States, Argentina and Brazil
and comprised one of the largest seed companies
in India. The majority of the Company was
acquired in April 2005 by the Monsanto Company
and its remaining operations were acquired in
June 2006 by Syngenta AG.
Sam began his career as an Analyst with the
US Department of Commerce's Bureau of Economic
Analysis, with responsibilities for modeling and
forecasting selected sectors of the US economy.
He was then employed by the Union Carbide
Corporation from 1974 to 1980, with
responsibilities for various aspects of new
corporate ventures. These transactions
involved extended assignments in Japan, Europe,
and South America.
In 1980, Sam led the spin-out of Union
Carbide's biotechnologies and related business
operations and was subsequently co-founder,
President and CEO of Agrigenetics Corporation.
The company grew to become one of the world's
largest seed enterprises and was acquired in
1985 -- it is now part of Dow AgroSciences.
During this same period, he was also chairman of
an affiliated partnership which managed and
invested $60 million in proprietary plant
sciences research conducted in leading
universities, as well as private and public
research institutions worldwide.
Following the sale of Agrigenetics, Sam
founded and was President of Big Stone Inc. -- a
private venture investment and development
company focused on the life sciences. The
firm participated in founding over a dozen
companies in area such as biopesticides, novel
nucleic acid-based therapeutics and diagnostic
products, transgenic animals, fermentation based
production of vitamins, pharmaceutical clinical
trialing, environmental toxicological testing
and bio therapeutics. Sam also served as
the non-executive chairman of Celgro, Inc, and
independent venture of Celgene Corporation, a
company focused on the development of novel,
single-isomer, agricultural chemical compounds.
In addition to his for-profit activities, Sam
has extensive pro-bono involvement in efforts
relating to food security and international
economic development. Currently he is an
advisor to The World Bank regarding rural
development strategy. He is a member of
the Board of Directors of the Global Crop
Diversity Trust. Sam serves on the Nation
Academies Panel on Science and Technology for
Global Sustainability. In the past, he
served on the Steering Committee for the Global
Assessment on Agricultural Science and
Technology, led by the World Bank. He was
a member of the Executive Council, as well as
chair of the Private Sector Committee, of the
Consultative Group on International Agricultural
Research. He has been as advisor to the
Rockefeller, McKnight and Macarthur Foundations
and a member of the Design Advisory Committee
and Scientific Advisory Board of its African
Agricultural Technology Foundation -- an
organization created for the advancement of
African food security. In the mid-1980's,
Sam chaired a Rockefeller Brothers Fund
development initiative to benefit developing
country food security. He aslo served on
the Board of the South/North Development
Initiative -- a private Rockefeller Family
foundation for alleviation of rural poverty in
less developed countries through entrepreneurial
development. He is a past member of the
U.S. Government's Agricultural Sciences and
Technology Review Board.
Sam is a member of the Council of Foreign
Relations and serves on its Advisory Committee
on Intellectual Property and American
Competitiveness. In the past he served on
its Study Group analyzing trade issues between
the United States and Europe surrounding
genetically modified foods.
He has written and lectured widely on the
policy issues of food security, the evolving
nature of global public goods and new mechanisms
for public and private sector relations.
In this regard, his travels have taken him on
missions to most countries in Latin America,
including Cuba, as well as Europe, Asia, Africa,
and the Middle East.
Sam is a native of eastern Kentucky, received
his B.A. degree in economics from Emory
university in 1973. |